{"id":"W4327698971","doi":"10.51731/cjht.2023.599","title":"Formulary Management of Targeted Immune Modulators in Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Ulcerative colitis; Infliximab; Biosimilar; Tofacitinib; Adalimumab; Ustekinumab; Formulary; Vedolizumab; Pharmacology; Immunology; Internal medicine; Rheumatoid arthritis; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001174446,0.0001119026,0.0004662819,0.0008744666,0.000107797,0.000005699962,0.0003248591,0.0002507247,0.0000620111],"category_scores_gemma":[0.0001351764,0.00009138333,0.00009047228,0.0008295226,0.0003281331,0.0000564243,0.00004427115,0.0004128388,0.000009041903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001755138,"about_ca_system_score_gemma":0.0003961453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001395231,"about_ca_topic_score_gemma":0.001601232,"domain_scores_codex":[0.9984685,0.0001548412,0.0007243399,0.0001190858,0.0000374112,0.0004958908],"domain_scores_gemma":[0.9993398,0.00006391933,0.0003139754,0.0001814924,0.00007550305,0.0000253494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001466093,0.0000654423,0.007916734,0.0004437741,0.0005598015,0.0005080802,0.0007639127,0.00004666175,0.002189544,0.02336077,0.00658306,0.9574156],"study_design_scores_gemma":[0.003492464,0.001702502,0.756194,0.001655252,0.00006968332,0.0002567369,0.02807542,0.00005536764,0.05750812,0.04154735,0.1088935,0.0005495822],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8670688,0.0946342,0.0005145531,0.03411687,0.001655858,0.0008077191,0.0001743208,0.0001860369,0.0008416874],"genre_scores_gemma":[0.9973983,0.001354165,0.0009504332,0.00009515171,0.000001557636,0.000004468198,0.000005816512,0.000007778463,0.0001823805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.956866,"threshold_uncertainty_score":0.3726504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02723269619042964,"score_gpt":0.2972221712317386,"score_spread":0.2699894750413089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}